|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$47,994
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$66,250
|
$6,625
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$5,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$299,734
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,277
|
$108,911
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-05
|
$290,571
|
$72,643
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$159,656
|
$159,656
|
Hakim, Frances
|
CCR (NCI)
|
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-05
|
$138,381
|
$138,381
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Transplanted Stem Cells and Tumor Progression
|
5R01CA118235-05
|
$265,423
|
$265,423
|
WONG, MELISSA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
|
Transplantation of G-CSF Stimulated Marrow vs Blood
|
5R01CA108752-05
|
$506,157
|
$506,157
|
Schultz, KIRK
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
|
Transplant Models
|
ZIA BC 010957
|
$1,013,465
|
$1,013,465
|
Gress, Ronald
|
CCR (NCI)
|
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
2T32CA009515-26
|
$616,306
|
$616,306
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
3P01CA044991-22S1
|
$250,000
|
$75,000
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
2P50CA083639-11
|
$2,231,452
|
$133,887
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The Therapy of CML
|
2P01CA049639-20A2
|
$3,596,592
|
$467,557
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
THE THERAPY OF AML
|
5P01CA055164-18
|
$2,483,417
|
$496,683
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
5R01CA071669-12
|
$375,750
|
$375,750
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
|
5K08CA131097-03
|
$120,606
|
$30,152
|
Krupnick, Alexander
|
WASHINGTON UNIVERSITY
|
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-04
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-32
|
$3,117,289
|
$3,117,289
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$544,555
|
$272,277
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Th1/Th17 Cell Differentiation in GVHD and GVL
|
1R01CA143812-01A1
|
$343,632
|
$343,632
|
YU, XUE-ZHONG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Telomere length after HSCT in patients with acquired severe aplastic anemia
|
ZIA CP010190 10508
|
$45,627
|
$45,627
|
Savage, Sharon
|
DCEG (NCI)
|
|
|
Techniques for modeling complex longitidinal studies
|
5R01CA054706-16
|
$233,320
|
$116,660
|
Klein, John
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
Targeting the leukemia microenvironment by CXCR4 inhibition in stem cell transpla
|
5R21CA137637-02
|
$338,800
|
$338,800
|
KONOPLEVA, MARINA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Targeting dendritic cells for selective modulation of GVHD
|
ZIA BC 011320
|
$150,905
|
$150,905
|
Fry, Terry
|
CCR (NCI)
|
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
5R01CA136551-02
|
$560,754
|
$280,377
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
|
1R01CA141303-01A1
|
$303,780
|
$303,780
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
9R01CA154244-06A1
|
$400,654
|
$400,654
|
Friedman, Thea
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
|
System for Rapid Generation of Aptamers for Transplant Therapies
|
1R43CA150490-01
|
$99,996
|
$99,996
|
Qian, Karen
|
CYNVENIO BIOSYSTEMS, INC.
|
|
|
SYNTHESES AND CELLULAR STUDIES OF NEW PHOTOSENSITIZERS FOR MEDICAL APPLICATIONS
|
5R01CA132861-02
|
$305,025
|
$76,256
|
Smith, Kevin
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
|
|
SunCoast CCOP Research Base at the University of South Florida
|
2U10CA081920-09
|
$1,220,157
|
$24,403
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$344,821
|
$258,616
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Sten Cell Gene Therapy of Breast Cancer
|
5R01CA136487-02
|
$325,237
|
$325,237
|
LIEBER, ANDRE
|
UNIVERSITY OF WASHINGTON
|
|
|
Stem cell manipulation via HOX gene regulation
|
5R01CA090833-09
|
$280,779
|
$140,390
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
|
|
Stanford University Cancer Center
|
2P30CA124435-04
|
$3,254,335
|
$325,434
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
3P30CA124435-04S1
|
$126,467
|
$12,647
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
3P30CA124435-04S2
|
$99,467
|
$9,947
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
3P30CA124435-04S3
|
$100,000
|
$10,000
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia
|
7K08CA120544-05
|
$133,272
|
$33,318
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Roswell Park Research Experience Program
|
5R25CA084473-10
|
$246,162
|
$49,232
|
MICHALEK, ARTHUR
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-34S1
|
$107,478
|
$1,075
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-34S2
|
$100,000
|
$1,000
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-34S3
|
$200,000
|
$2,000
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-34S4
|
$100,000
|
$1,000
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Roswell Park Cancer Institute Center Support Grant
|
5P30CA016056-34
|
$4,168,904
|
$41,689
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Research and Mentoring in Psychosocial Oncology
|
5K05CA108955-07
|
$161,595
|
$121,196
|
Redd, William
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$183,397
|
$183,397
|
Bishop, Michael
|
CCR (NCI)
|
|
|
Regulation of Tumor Associated Macrophages by TGF-beta
|
5R01CA132571-03
|
$287,283
|
$143,642
|
Keshamouni, Venkateshwar
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
REGULATION OF ANTI-TUMOR IMMUNITY
|
3P01CA109094-04S1
|
$42,298
|
$10,575
|
PODACK, ECKHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Total relevant funding to Bone Marrow Transplantation for this search: $64,195,092
|
